Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

False high testosterone levels were corrected using a more accurate test.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS and suggest the need for further tests for related health issues.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Mutations in the androgen receptor gene cause various disorders.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Physicians in China prioritize clinical hyperandrogenism in PCOS treatment, but clearer guidelines are needed.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

Advances in genetics may lead to targeted treatments for hair disorders.

Hair analysis is valuable for health and forensics but faces challenges like growth variability and contamination.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Early diagnosis and treatment with biotin are crucial for preventing severe outcomes in certain conditions.

Biotinidase deficiency can be easily diagnosed and treated with biotin to prevent serious harm.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Hair loss in women is complex to diagnose and treat, and hair restoration should be done by experts. Using minoxidil before surgery can help manage post-surgery hair shock loss. The Follicular Unit Transplantation method is recommended for women due to its speed, no need for shaving, and better graft quality. Strategies like L, T, and reverse L patterns can help restore central hair density, and regenerative methods can improve graft survival in hair transplants.

Genetic testing is crucial for diagnosing and treating acrodermatitis enteropathica effectively.

Ultrasound alone isn't enough to diagnose PCOS.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.